Legis Daily

A bill to amend title XVIII of the Social Security Act to encourage the development and use of DISARM antimicrobial drugs, and for other purposes.

USA115th CongressS-3787| Senate 
| Updated: 12/19/2018
Orrin G. Hatch

Orrin G. Hatch

Republican Senator

Utah

Cosponsors (1)
Robert P. Casey (Democratic)

Finance Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2018 or the DISARM Act of 2018 This bill requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 19, 2018
Introduced in Senate
Dec 19, 2018
Read twice and referred to the Committee on Finance.
  • December 19, 2018
    Introduced in Senate


  • December 19, 2018
    Read twice and referred to the Committee on Finance.

Health

Congressional oversightDrug safety, medical device, and laboratory regulationDrug therapyGovernment information and archivesGovernment studies and investigationsInfectious and parasitic diseasesMedicare

A bill to amend title XVIII of the Social Security Act to encourage the development and use of DISARM antimicrobial drugs, and for other purposes.

USA115th CongressS-3787| Senate 
| Updated: 12/19/2018
Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2018 or the DISARM Act of 2018 This bill requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 19, 2018
Introduced in Senate
Dec 19, 2018
Read twice and referred to the Committee on Finance.
  • December 19, 2018
    Introduced in Senate


  • December 19, 2018
    Read twice and referred to the Committee on Finance.
Orrin G. Hatch

Orrin G. Hatch

Republican Senator

Utah

Cosponsors (1)
Robert P. Casey (Democratic)

Finance Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Congressional oversightDrug safety, medical device, and laboratory regulationDrug therapyGovernment information and archivesGovernment studies and investigationsInfectious and parasitic diseasesMedicare